IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitors

Experimental Gerontology

Volumn 39, Issue 4, 2004, Pages 653-657

  Lugaresi, Alessandra ^a   Di Iorio, Angelo ^a   Iarlori, Carla ^a   Reale, Marcella ^a   De Luca, Giovanna ^a   Sparvieri, Eleonora ^a   Michetti, Alessia ^a   Conti, Pio ^a   Gambi, Domenico ^a   Abate, Giuseppe ^a   Paganelli, Roberto ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Acetylcholinesterase inhibitors; Aging; Alzheimer's disease; Cytokines; Interleukin 4

Indexed keywords

CHOLINESTERASE INHIBITOR; CONCANAVALIN A; CYTOKINE; INTERLEUKIN 4; PHYTOHEMAGGLUTININ;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; CELL CULTURE; CLINICAL ARTICLE; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LINEAR REGRESSION ANALYSIS; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEX DIFFERENCE; UPREGULATION;

AGED; ALZHEIMER DISEASE; CELLS, CULTURED; CHOLINESTERASE INHIBITORS; CONCANAVALIN A; FEMALE; HUMANS; INTERLEUKIN-4; MALE; NOOTROPIC AGENTS; PHYTOHEMAGGLUTININS; UP-REGULATION;

EID: 12144285619     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2003.08.012     Document Type: Conference Paper

References (23)

1. Alvarez X.A., Mouzo R., Pichel V., Perez P., Laredo M., Fernandez-Novoa L., Corzo L., Zas R., Alcaraz M., Secades J.J., Lozano R., Cacabelos R. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion. Methods Find. Exp. Clin. Pharmacol. 21:1999;633-644.
2. Araujo D.M., Cotman C.W. Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res. 600:1993;49-55.
3. Chao C.C., Molitor T.W., Hu S. Neuroprotective role of IL-4 against activated microglia. J. Immunol. 151:1993;1473-1481.
4. Combs C.K., Karlo J.C., Kao S.C., Landreth G.E. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha- dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21:2001;1179-1188.
5. Deretzi G., Pelidou S.H., Zou L.P., Wei L., Nennesmo I., Zhu J. High inflammation and mild demyelination in the peripheral nervous system induced by an intraneural injection of RR interleukin-4. Cytokine. 12:2000;808-810.
6. Griffin W.S., Sheng J.G., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I., Roberts G.W., Mrak R.E. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 8:1998;65-72.
7. Haas J., Storch-Hagenlocher B., Biessmann A., Wildemann B. Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro. Neurosci. Lett. 322:2002;121-125.
8. Jonnala R.R., Buccafusco J.J. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. J. Neurosci. Res. 66:2001;565-572.
9. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 9:1969;179-186.
10. Li Y., Liu L., Kang J., Sheng J.G., Barger S.W., Mrak R.E., Griffin W.S. Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J. Neurosci. 20:2000;149-155.
11. Navikas V., Matusevicius D., Soderstrom M., Pirskanen R., Fredrikson S., Link H. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis. Clin. Neuropharmacol. 21:1998;236-244.
12. Nijhuis E.W., Oostervink F., Hinloopen B., Rozing J., Nagelkerken L. Differences in dexamethasone-sensitivity between lymphocytes from patients with Alzheimer's disease and patients with multi-infarct dementia. Brain Behav. Immun. 10:1996;115-125.
13. NINCDS-ADRDA Work Group. Criteria for the clinical diagnosis of Alzheimer's disease. J. Am. Geriatr. Soc. 33:1985;2-3.
14. Okuma Y., Nomura Y. Roles of muscarinic acetylcholine receptors in interleukin-2 synthesis in lymphocytes. Jpn. J. Pharmacol. 85:2001;16-19.
15. Paganelli R., Di Iorio A., Patricelli L., Ripani F., Sparvieri E., Faricelli R., Iarlori C., Di Gioacchino M., Abate G. Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer's disease patients. Exp. Gerontol. 37:2002;257-263.
16. Parmelee P.A., Thuras P.D., Katz I.R., Lawton M.P. Validation of the Cumulative Illness Rating Scale in a geriatric residential population. J. Am. Geriatr. Soc. 43:1995;130-137.
17. Schubert P., Morino T., Miyazaki H., Ogata T., Nakamura Y., Marchini C., Ferroni S. Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. Ann. NY Acad. Sci. 903:2000;24-33.
18. Sholl-Franco A., Figueiredo K.G., de Araujo E.G. Interleukin-2 and interleukin-4 increase the survival of retinal ganglion cells in culture. NeuroReport. 12:2001;109-112.
19. Soderstrom M., Hillert J., Link J., Navikas V., Fredrikson S., Link H. Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease. Mult. Scler. 1:1995;173-180.
20. Szczepanik A.M., Funes S., Petko W., Ringheim G.E. L-4, IL-10 and IL-13 modulate A beta(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J. Neuroimmunol. 113:2001;49-62.
21. Viel J.J., McManus D.Q., Smith S.S., Brewer G.J. Age- and concentration-dependent neuroprotection and toxicity by TNF in cortical neurons from beta-amyloid. J. Neurosci. Res. 64:2001;454-465.
22. Vitek M.P., Snell J., Dawson H., Colton C.A. Modulation of nitric oxide production in human macrophages by apolipoprotein-E and amyloid-beta peptide. Biochem. Biophys. Res. Commun. 240:1997;391-394.
23. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Wang H., Yang H., Ulloa L., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Wang H., Yang H., Ulloa L., Al Abed Y., Czura C.J., Tracey K.J. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 421:2003;384-388.